Skip to main content

CompoSecure Inc

For the period ended Dec 31, 2024. Filed Mar 5, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 5, 2025

GPGI$14.95-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Notes to Consolidated Financial Statements

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

  1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

CompoSecure, Inc. (“CompoSecure” or the “Company”) is a manufacturer and designer of complex metal, composite and proprietary financial transaction cards. The Company was founded and commenced operations in 2000. The Company provides products and services primarily to global financial institutions, plastic card manufacturers, system integrators, and security specialists. The Company is located in Somerset, New Jersey. Since its inception, the Company has established itself as a technology partner to market leaders, fintechs and consumers enabling trust for millions of people around the globe. The Company combines elegance, simplicity and security to deliver exceptional experiences and peace of mind in the physical and digital world. The Company’s innovative payment card technology and metal cards with Arculus secure authentication and digital asset storage capabilities deliver unique, premium branded experiences, enable people to access and use their financial and digital assets, and ensure trust at the point of a transaction.

The Company creates newly innovated, highly differentiated and customized quality financial payment products for banks and other payment card issuers to support and increase their customer acquisition, customer retention and organic customer spend. The Company’s customers consist primarily of leading international and domestic banks and other payment card issuers primarily within the United States (“U.S.”), with additional direct and indirect customers in Europe, Asia, Latin America, Canada, and the Middle East. The Company is a platform for next generation payment technology, security, and authentication solutions. The Company maintains trusted, highly-embedded and long-term customer relationships with an expanding set of global issuers. The Company has established a niche position in the financial payment card market with over 20 years of innovation and experience and is focused primarily on this attractive subsector of the financial technology market. The Company serves a diverse set of direct customers and indirect customers, including some of the largest issuers of credit cards in the U.S.

On December 27, 2021 (the "Closing Date"), Roman DBDR Tech Acquisition Corp ("Roman DBDR") consummated the merger pursuant to the Merger Agreement, dated April 19, 2021 (the "Merger Agreement"), by and among Roman DBDR, Roman Parent Merger Sub, LLC, a wholly-owned subsidiary of Roman DBDR incorporated in the State of Delaware ("Merger Sub"), and CompoSecure Holdings, L.L.C., a Delaware limited liability company ("Holdings"). Pursuant to the terms of the Merger Agreement, a business combination between the Company and Holdings was affected through the merger of Merger Sub with and into Holdings, with Holdings as the surviving company and as a wholly-owned subsidiary of Roman DBDR (the "Business Combination"). Pursuant to the Business Combination, the merger was accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the U.S. ("U.S. GAAP"). On the Closing Date, and in connection with the closing of the Business Combination, Roman DBDR changed its name to CompoSecure, Inc. Holdings was deemed the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification ("ASC") 805. This determination was primarily based on Holdings' members prior to the Business Combination having a majority of the voting interests in the combined company, Holdings' operations comprising the ongoing operations of the combined company, Holdings' members and officers comprising a majority of the board of directors of the combined company, and Holdings' senior management comprising the senior management of the combined company. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Holdings issuing stock for the net assets of Roman DBDR, accompanied by a recapitalization. The net assets of Roman DBDR were stated at historical cost, with no goodwill or other intangible assets recorded. While Roman DBDR was the legal acquirer in the Business Combination, because Holdings was deemed the accounting acquirer, the historical financial statements of Holdings became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the financial statements included in this report reflect (i) the historical operating results of Holdings prior to the Business Combination; (ii) the combined results of the Company and Holdings following the closing of the Business Combination; (iii) the assets and liabilities of Holdings at their historical cost; and (iv) the Company’s equity structure for all periods presented. In accordance with guidance applicable to these circumstances, the equity structure was restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company's common stock, $0.0001 par value per share issued to Holdings' equity holders in connection with the recapitalization transaction. As such, the shares and corresponding capital amounts and earnings per share related to Holdings' common stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination Agreement.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Prior to the Resolute Transaction, the Company had operated as an umbrella partnership C corporation (“Up-C”), meaning that the sole asset of CompoSecure, Inc. was its interest in Holdings and the related deferred tax asset. Holdings had been an entity taxed as a partnership for U.S. federal income tax purposes and, until the Resolute transaction (described below), was owned by both the historical owners and CompoSecure, Inc. By virtue of control of the board of managers of Holdings, CompoSecure, Inc. operates and controls the business and affairs of CompoSecure. As a result, the Company consolidates the financial results of Holdings and, through December 31, 2024, has reported a non-controlling interest related to the Holdings units not owned by CompoSecure, Inc through the time of the Resolute Transaction which resulted in the elimination of the non-controlling interest.

On August 7, 2024, all of the Class B stockholders of the Company and affiliates of Resolute Compo Holdings, LLC, including Tungsten 2024 LLC ("Resolute") entered into stock purchase agreements, pursuant to which the selling shareholders would exchange their 51,908,422 Class B units (and corresponding Class B shares) for Class A shares, eliminating the Company's existing dual-share class structure. On September 17, 2024, the transactions (the "Resolute Transaction") closed and Resolute became the majority owner of the Company by acquiring 49,290,409 shares of Class A Common Stock of the Company for an aggregate purchase price of approximately $372 million, or $7.55 per share, representing an approximately 60% voting interest. The Company was not party to the stock purchase agreements. Prior to these transactions, Class B holders held Class B units in Holdings. Subsequent to the Resolute Transaction, CompoSecure owned 100% of Holdings. As a result of the Resolute Transaction, the Company no longer had Class B shares outstanding as of the closing date. At December 31, 2024, Resolute held approximately 49.9% of the voting interest in the Company resulting from dilution from additional issuances of Class A shares by the Company).

  1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying consolidated financial statements are presented in conformity with generally accepted accounting principals in the United States ("U.S. GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Any reference in these notes to applicable guidance is meant to refer to U.S. GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASU”) promulgated by the Financial Accounting Standards Board (“FASB”). The accompanying consolidated financial statements include the results of operations of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain reclassifications have been made to conform to the current year presentation. All dollar amounts are in thousands, unless otherwise noted. Share and per share amounts are presented on a post-conversion basis for all periods presented, unless otherwise noted.

Use of Estimates

The preparation of the consolidated financial statements requires management to make a number of estimates and assumptions relating to the reported amount of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. The Company bases its estimates on historical experience, current business factors and various other assumptions believed to be reasonable under the circumstances, all of which are necessary in order to form a basis for determining the carrying values of assets and liabilities. Actual results may differ from those estimates and assumptions. The Company evaluates the adequacy of its reserves and the estimates used in calculations on an on-going basis. Significant areas requiring management to make estimates include the valuation of equity instruments, measurement of changes in the fair value of earnout consideration liability, estimates of derivative liability associated with the Exchangeable Notes (as defined below), which were marked to market each quarter based on a Lattice model approach, derivative asset for the interest rate swap, changes in the fair value of warrant liabilities, valuation allowances on deferred tax assets which are based on an assessment of recoverability of the deferred tax assets against future taxable income and stimates of the inputs used to calculate the tax receivable agreement liability, reserve for excess and obsolete inventory, estimated useful lives and impairment of property and equipment, and lease term, discount rates and other inputs used to measure right of use assets and lease liabilities.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Cash and Cash Equivalents

Cash and cash equivalents consist of cash and short-term investments with original maturities from the purchase date of three months or less that can be readily converted into known amounts of cash. Cash and cash equivalents are held at recognized U.S. financial institutions. Interest earned is reported in the consolidated statements of operations. The carrying amount of cash and cash equivalents approximates its fair value due to its short-term and liquid nature.

Accounts Receivable

Accounts receivable are recognized net of allowances for credit losses. Allowance for credit losses are established based on an evaluation of accounts receivable aging, and, where applicable, specific reserves on a customer-by-customer basis, creditworthiness of the Company’s customers and prior collection experience to estimate the ultimate collectability of these receivables. At the time the Company determines that a receivable balance, or any portion thereof, is deemed to be permanently uncollectible, the balance is then written off. The Company didnot recognize any allowance for credit losses at December 31, 2024 and 2023.

Inventories

Inventories are stated at the lower of cost or net realizable value, a basis that approximates the first-in, first out method. Inventories consist of raw material, work in process and finished goods. The Company establishes reserves as necessary for obsolescence and excess inventory. The Company records a reserve for excess and obsolete inventory based upon a calculation using the historical experience, expected future sales volumes, the projected expiration of inventory and specifically identified obsolete inventory.

Property and Equipment

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is computed on a straight-line basis over the estimated useful lives of the assets, which ranges fromone toten years. Leasehold improvements are recorded at cost, less accumulated amortization, which is computed on straight-line basis over the shorter of the useful lives of the assets or the remaining lease term. Expenditures for maintenance and repairs are charged to expense as incurred. The Company evaluates the depreciation periods of property and equipment to determine whether events or circumstances indicate that the asset’s carrying value is not recoverable or warrant revised estimates of useful lives. No impairment charges or revisions in the estimated useful lives of property and equipment were made during the years ended December 31, 2024 and 2023.

Investments

In November 2024, the Company invested $1,500 in a Simple Agreement for Future Equity ("SAFE") with Signify Holdings, Inc., also known as Rain Cards. Rain Cards is an issuer with the Visa Network and offers solutions for card programs across a number of regions and use cases. In accordance with ASC 321, Investments, the Company has elected to account for this investment at cost. No impairment was recorded on the investment during the year ended December 31, 2024. Investment in SAFE are included as part of the deposits and other assets line item on the consolidated balance sheet.

Revenue Recognition

The Company recognizes revenue in accordance with ASU 2014-09, Revenue From Contracts With Customers (Topic 606) (“ASC 606”) when the performance obligations under the terms of the Company’s contracts with its customers have been satisfied. This occurs at the point in time when control of the specific goods or services as specified by each purchase order are transferred to customers. Specific goods refers to the products offered by the Company, including metal cards, high security documents, and pre-laminated materials. Transfer of control passes to customers upon shipment or upon receipt, depending on the agreement with the specific customers. ASC 606 requires entities to record a contract asset when a performance obligation has been satisfied or partially satisfied, but the amount of consideration has not yet been received because the receipt of the consideration is conditioned on something other than the passage of time. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g. receivable), before the entity transfers a good or service to the customer. The Company didnot have any contract assets or liabilities as of December 31, 2024 and 2023.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The Company invoices its customers at the time at which control is transferred, with payment terms ranging between 15 and 60 days depending on each individual contract. As the payment is due within 60 days of the invoice, a significant financing component is not included within the contracts.

The majority of the Company’s contracts with its customers have the same performance obligation of manufacturing and transferring the specified number of cards to the customer. Each individual card included within an order constitutes a separate performance obligation, which is satisfied upon the transfer of goods to the customer. The contract term as defined by ASC 606 is the length of time it takes to deliver the goods or services promised under the purchase order or statement of work. As such, the Company's contracts are generally short term in nature.

Revenue is measured in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. Revenue is recognized net of variable consideration such as discounts, rebates, and returns which is measured based on the expected value or most likely amount of variable consideration, as applicable.

The Company’s products do not include an unmitigated right of return unless the product is non-conforming or defective. If the goods are non-conforming or defective, the defective goods are replaced or reworked or, in certain instances, a credit is issued for the portion of the order that was non-conforming or defective. A provision for sales returns and allowances is recorded based on experience with goods being returned. Most returned goods are re-worked and subsequently re-shipped to the customer and recognized as revenue. Historically, returns have not been material to the Company.

Additionally, the Company has a rebate program with certain customers allowing for a rebate based on achieving a certain level of shipped sales during the calendar year. This rebate is estimated and updated throughout the year and recorded against revenues and the related accounts receivable.

On occasion, the Company receives requests from customers to hold purchased products. The Company evaluates these requests as bill and hold arrangements. The Company recognizes revenue from such bill and hold arrangements in accordance with the guidance provided in ASC 606, which indicates that for a customer to have obtained control of a product in a bill and hold arrangement, all of the following criteria must be met: (a) the reason for the bill and hold is substantive, (b) the product has separately been identified as belonging to the customer, (c) the product is currently ready for physical transfer to the customer, and (d) the Company does not have the ability to use the product or direct it to another customer. During the years ended December 31, 2024, 2023, and 2022 the Company recognized $8,085, $0 and $2,300 ofrevenue under bill and hold arrangements, respectively.

Significant Judgments in Application of the Guidance

Management exercises judgment when determining the amount of revenue to be recognized each period. Such judgments include, but are not limited to, assessing the customer’s ability and intention to pay substantially all of the contract consideration when due, assessing whether promises are immaterial in the context of the contract, determining whether material promises in a contract represent distinct performance obligations, estimating the transaction price for a contract that contains variable consideration, determining the stand-alone selling price of each performance obligation, and determining the point in time when control is transferred to the customer.

Practical Expedients and Exemptions

As permitted by ASC 606, the Company uses certain practical expedients in connection with the application of ASC 606. The Company accounts for shipping and handling activities as fulfillment activities. The Company accounts for costs associated with obtaining new contracts as expenses when incurred if the amortization period of the asset that would be recognized is one year or less. The Company does not adjust the transaction price for significant financing components, as the Company’s contracts typically do not contain provisions for significant advance or deferred payments, nor do they span more than a one year period. The Company applies the optional exemption to not disclose information regarding the allocation of transaction price to remaining performance obligations with an original expected duration of less than one year.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Shipping and Handling Costs

Shipping and handling are recognized in cost of goods sold in the consolidated statements of operations. Total shipping and handling costs were approximately $2,451, $2,286 and $2,755 for the years ended December 31, 2024, 2023, and 2022, respectively.

Research and Development Costs

Research and development costs are expensed as incurred and were$7,441, $6,780 and $6,723 for the years ended December 31, 2024, 2023, and 2022, respectively.

Advertising

The Company expenses the cost of advertising as incurred. Advertising expense of approximately $4,782, $5,020, and $11,808 for the years ended December 31, 2024, 2023, and 2022, respectively, are included in selling, general and administrative expenses in the consolidated statements of operations.

Income Taxes

Income taxes are applied to the income attributable to the controlling interest (see Note 13) as the income attributable to the non-controlling interest is pass-through income. Prior to the Business Combination, the Company was not subject to income taxes due to its prior equity structure and was, instead, subject to pass through income taxes. The Company complies with the accounting and reporting requirements of ASC Topic 740, Income Taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

The Company will continue to evaluate the realizability of our deferred tax assets and liabilities on a quarterly basis, and will adjust such amounts in light of changing facts and circumstances, including but not limited to future projections of taxable income, tax legislation, rulings by relevant tax authorities and the progress of ongoing tax audits, if any. The Company considers all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized in future periods.

Prior to the Resolute Transaction, Holdings was a partnership for tax purposes. Pursuant to Holdings’ limited liability company agreement, during a portion of fiscal 2024 (and prior years), Holdings made pro rata tax distributions to its members. These distributions were based on the Company’s estimate of taxable income for each year, updated throughout the year. Tax distributions from Holdings were intended to provide each member of Holdings sufficient funds to meet tax obligations with respect to the taxable income of Holdings allocated to each member. The Holdings limited liability company agreement required distributions to be calculated based on a tax rate equal to the highest combined marginal federal and applicable state or local statutory income tax rate applicable to an individual resident in New York City, New York, including the Medicare contribution tax on unearned income, taking into account all jurisdictions in which the Company is required to file income tax returns together with the relevant apportionment information subject to various adjustments. As a result of the Resolute Transaction, CompoSecure, Inc. is the only owner of Holdings.

For the year ended December 31, 2024, Holdings distributed a total of $50,082 of tax distributions to its members, of which $15,219 was paid to CompoSecure, Inc. (the parent company), resulting in a net tax distribution to all other members of $34,863. For the year ended December 31, 2023, Holdings distributed a total of $49,955 of tax distributions to its members, of which $11,593 was paid to CompoSecure, Inc. (the parent company), resulting in a net tax distribution to all other members of $38,362. For the year ended December 31, 2022, Holdings distributed a total of $44,434 of tax distributions to its members, of which $8,141 was paid to CompoSecure, Inc. (the parent company), resulting in a net tax distribution to all other members of $36,293.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Stock-Based Compensation

The Company has equity-based compensation plans which are described in more detail in Note 9. Compensation cost relating to equity-based awards as provided by the arrangements are recognized in the consolidated statements of operations over the requisite service period based on the grant date fair value of such awards. The Company determines the fair value of each award on the date of grant using the methodology commonly accepted for the respective award. See Note 9 for a discussion of the valuation of equity-based compensation.

As a result of the Business Combination, certain of Holdings' equity holders had the right to receive an aggregate of up to 7,500,000 additional shares of the Company's Class A Common Stock in earnout consideration (the "Earnout Shares") based on the achievement of certain stock price thresholds (See Note 18 in Notes to Consolidated Financial Statements in this Form 10-K for further discussion) (collectively, the “Earnouts”). The Earnouts are subject to two price thresholds, with half to be awarded upon the achievement of each threshold. The Earnouts expire in two phases if the achievement thresholds are not met. The first phase was to expire upon thethree year anniversary of the Closing Date, and the second phase is set to expire upon thefour year anniversary. The Earnouts under the first phase were achieved on December 13, 2024. The second phase Earnout, which expires December 27, 2025, has not yet been achieved.

The valuation of the Earnouts was determined using a Monte Carlo simulation model that utilizes significant assumptions, including volatility, that determine the probability of satisfying the market condition stipulated in the award to calculate the fair value of the award. The Company classifies the Earnouts as liabilities at their fair value on the consolidated balance sheet and adjusts the fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until expiration, and any change in fair value is recognized in revaluation of Earnout consideration liability in the Company's consolidated statements of operations. A portion of the liability was considered compensation and fully expensed at inception. See Note 9 and 11.

Warrant Liability

The Company accounts for the warrants in accordance with the guidance contained in ASU 2017-12, Derivatives and Hedging (Topic 815)(“ASC 815”). As the warrants did not meet the criteria for equity treatment in accordance with ASC 815, the warrants were recorded as liabilities on the consolidated balance sheets. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in revaluation of warrant liability in the Company's consolidated statements of operations. The warrants were valued using the quoted market price as of each balance sheet date. See Note 11 for more details.

Tax Receivable Agreement Liability

As a result of the Business Combination, the Company entered into a tax receivable agreement (the “Tax Receivable Agreement”) with Holdings and holders of interests in Holdings as of the date of the Business Combination (the "TRA Holders"). Pursuant to the Tax Receivable Agreement, the Company is required to pay to the TRA Holders 90% of the amount of savings, if any, in U.S. federal, state and local income tax that the Company actually realizes as a result of the utilization of certain tax attributes. The tax receivable agreement will continue until all such tax benefits have been utilized or expired unless the Company exercises its right to terminate the agreement for an amount representing the present value of anticipated future tax benefits under the tax receivable agreement. The Company will retain the benefit of the remaining 10% of these cash tax savings. The Company recorded $253,705 and $25,374 in tax receivable agreement liability as of December 31, 2024 and 2023, respectively which is reported in the Company's consolidated balance sheets. The Company paid $1,303 and $2,436 during the years ended December 31, 2024 and December 31, 2023, respectively to the TRA Holders pursuant to the savings in U.S. federal, state and local income taxes that the Company realized as a result of the utilization of certain tax attributes for the fiscal years 2023 and 2022.

Selling, General and Administrative

Selling, general and administrative (“SG&A”) expenses primarily include expenses related to salaries and commissions, transaction costs, and professional fees. Included in SG&A during the years ended December 31, 2024, 2023,

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

and 2022 were salaries and commissions of $31,478, $30,108, and $35,650, and professional fees of $24,916, $13,664, and $14,024, respectively.

Net (Loss) Income Per Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common share is computed by dividing net (loss) income attributable to controlling interest by the weighted average number of common shares outstanding for the period. The weighted-average number of common shares outstanding during the period includes Class A Common Stock but was exclusive of Class B Common Stock (while outstanding) as these shares have no economic or participating rights.

Diluted net (loss) income per share is computed by dividing the net (loss) income allocated to potential dilutive instruments attributable to controlling interest by the basic weighted-average number of common shares outstanding during the period, adjusted for the potentially dilutive shares of common stock equivalents resulting from the assumed exercise of the warrants, payment of the earnouts, exercise and vesting of the equity awards, exchange of the Class B units and Exchangeable Notes ("securities") only if the effect is not anti-dilutive.

Market and Credit Risk

Financial instruments that potentially subject the Company to credit risk consist principally of investments in cash, cash equivalents, short-term investments and accounts receivable. The Company’s primary exposure is credit risk on receivables as the Company does not require any collateral for its accounts receivable. Credit risk is the loss that may result from a trade customer’s or counterparty’s nonperformance. The Company uses credit policies to control credit risk, including utilizing an established credit approval process, monitoring customer and counterparty limits, monitoring changes in a customer’s credit rating, employing credit mitigation measures such as analyzing customers’ financial statements, and accepting personal guarantees and various forms of collateral. The Company believes that its customers and counterparties will be able to satisfy their obligations under their contracts.

The Company maintains cash and cash equivalents with approved federally insured financial institutions. Such deposit accounts at times may exceed federally insured limits. The Company is exposed to credit risks and liquidity in the event of default by the financial institutions or issuers of investments in excess of FDIC insured limits. The Company performs periodic evaluations of the relative credit standing of these financial institutions and limits the amount of credit exposure with any institution if required. The Company has not experienced any losses on such accounts.

Fair Value Measurements

The Company determines fair value in accordance with ASC 820 Fair Value Measurement(“ASC 820”) which established a hierarchy for the inputs used to measure the fair value of financial assets and liabilities based on the source of the input, which generally range from quoted prices for identical instruments in a principal trading market i.e. Level 1 to estimates determined using significant unobservable inputs i.e. Level 3. The fair value hierarchy prioritizes the inputs, which refer to assumptions that market participants would use in pricing an asset or liability, based upon the highest and best use, into three levels as follows:

The standard describes three levels of inputs that may be used to measure fair value:

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2: Observable inputs other than unadjusted quoted prices in active markets for identical assets or liabilities such as:

Quoted prices for similar assets or liabilities in active markets

Quoted prices for identical or similar assets or liabilities in inactive markets

Inputs other than quoted prices that are observable for the asset or liability

Inputs that are derived principally from or corroborated by observable market data by correlation or other mean

Level 3: Unobservable inputs in which there is little or no market data available, which are significant to the fair value measurement and require the Company to develop its own assumptions.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The Company’s financial assets and liabilities measured at fair value consisted of cash and cash equivalents, accounts receivable, accounts payable, debt, warrants, earnout consideration and interest rate swap. Cash and cash equivalents consisted of bank deposits and short-term investments, such as money market funds, the fair value of which is based on quoted market prices, a Level 1 fair value measure. As of December 31, 2024 and 2023, the carrying values of cash, cash equivalents, accounts receivable and accounts payable approximate fair value because of the short-term maturity of these instruments. The Exchangeable Notes were all converted during the year ended December 31, 2024. The fair value of the Company’s Exchangeable Notes without the make-whole feature was approximately $118,000 as of December 31, 2023. The Company accounts for financial assets and liabilities that are re-measured and reported at fair value at each reporting period in accordance with ASC 820. See Note 11.

Software Development Costs

The Company applies the principals of FASB ASC 350-40, Accounting for the Cost of Computer Software Developed or Obtained for Internal Use ("ASC 350-40"). ASC 350-40 requires that software development costs incurred before the preliminary project stage be expensed as incurred. The Company capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed and the software will be used to perform the functions intended. The Company capitalized $1,035 of software development costs during the year ended December 31, 2024. No software development costs were capitalized during the year ended December 31, 2023. Capitalized software costs are presented as part of deposits and other assets on the consolidated balance sheets. The carrying value of capitalized software was $985 as of December 31, 2024. There wasno capitalized software as of December 31, 2023. Capitalized software is amortized betweentwo andthree years.

Recent Accounting Pronouncements

On November 4, 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disaggregated disclosure of income statement expenses for public business entities ("PBEs"). The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. ASU 2024-03 is effective for all PBEs for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is still assessing the impact that the adoption of this ASU will have on the Company's consolidated financial statements.

On December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which applies to

all entities subject to income taxes. For PBEs, the new requirements will be effective for annual periods beginning after December 15, 2024. For entities other than public business entities ("non-PBEs"), the requirements will be effective for annual periods beginning after December 15, 2025. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The amendments in this update require that public business entities on an annual basis disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold if the effect of those reconciling items is equal to or greater than five percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate. The new guidance focuses on two specific disclosure areas: rate reconciliation and income taxes paid. The rate reconciliation disclosure requirements differ for PBEs as compared to non-PBEs. The income taxes paid disclosures are the same for all entities. The Company will adopt this ASU on January 1, 2025 and is still assessing the impact that the adoption of this ASU will have on the Company's consolidated financial statements.

On November 27, 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), which applies to all public entities that are required to report segment information in accordance with Topic 280, Segment Reporting. The guidance will be applied retrospectively and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance improves financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful financial analysis. The Company adopted ASU 2023-07 during the year ended December 31, 2024 and has reflected updates to its segment reporting in the Company's consolidated financial statements.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

  1. REVENUE RECOGNITION

The Company recognizes revenue in accordance with accounting standard ASC 606 when the performance obligations under the terms of the Company’s contracts with its customers have been satisfied. See Note 2.

The following percentages present the Company’s revenue concentration by customer. The majority of the Company’s revenue is earned from major contracts. Aggregate revenue from the two top customers comprised approximately 63.2%,70.5% and 67.3% of total revenue for the years ended December 31, 2024, 2023 and 2022, respectively.

  1. INVENTORIES

The major classes of inventories were as follows:

December 31,
20242023
Raw materials$46,109$50,867
Work in process1,0244,110
Finished goods505662
Inventory reserve(2,805)(3,099)
$44,833$52,540

The Company reviews inventory for slow moving or obsolete amounts based on expected product sales volume and provides reserves against the carrying amount of inventory as appropriate.

  1. PROPERTY AND EQUIPMENT

Property and equipment consisted of the following:

December 31,
Useful Life20242023
Machinery and equipment5 - 10 years$38,012$30,311
Furniture and fixtures3 - 5 years3333
Computer equipment3 - 5 years462
Leasehold improvementsShorter of lease term or estimated useful life11,71110,609
Vehicles5 years88—
Software1 - 3 years1,7181,718
Construction in progress2,6644,189
Total54,27246,862
Less: Accumulated depreciation and amortization(30,824)(21,650)
Property and equipment, net$23,448$25,212

Depreciation and amortization expense for the years ended December 31, 2024, 2023, and 2022, was $9,174, $8,387, and $8,575, respectively.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

  1. DEBT

Exchangeable Senior Notes

On December 27, 2021, the Company completed the Business Combination discussed in Note 1. On April 19, 2021, concurrent with the execution of the Merger Agreement, the Company and its subsidiary, Holdings, entered into subscription agreements (the “Note Subscription Agreements”) with certain investors ("Notes Investors") pursuant to which such Notes Investors, severally and not jointly, purchased on December 27, 2021, the closing date of the Business Combination (the Closing Date"), the Exchangeable Notes issued by Holdings and guaranteed by its operating subsidiaries, CompoSecure, L.L.C. and Arculus Holdings, L.L.C., in an aggregate principal amount of up to $130,000 that were exchangeable into shares of Class A Common Stock at a conversion price of $11.50 per share, subject to the terms and conditions of an Indenture ntered into by the Company and its wholly owned subsidiary, Holdings and the trustee under the Indenture.

On June 11, 2024, the Company paid a special cash dividend to Class A shareholders of CompoSecure, Inc., and made a corresponding distribution to Class B unitholders of Holdings. As a result of the special cash dividend and distribution, the conversion price was adjusted to $10.98 per share, which resulted in an adjustment to the exchange rate to 91.0972 shares of the Company’s Class A Common Stock per $1,000 principal amount of Notes exchanged. On September 17, 2024, the Resolute Transaction closed, where a majority interest of the Company was acquired through privately negotiated sales. See Note 9 for additional information on the special cash dividend and sale of the majority interest.

The sale of the majority interest and subsequent filing of a Schedule 13D report with the SEC by Resolute on September 19, 2024 triggered the occurrence of a “Make-Whole Fundamental Change” (as defined in the Indenture), pursuant to which the Company, on September 20, 2024, issued a Notice of Make-Whole Fundamental Change to the holders of the Exchangeable Notes to notify the holders that the exchange rate for the Exchangeable Notes has been temporarily increased from 91.0972 shares of Class A Common Stock per $1,000 principal amount of Notes to 104.5199 shares of Class A Common Stock per $1,000 principal amount of notes. This temporary increase in the exchange rate resulted in an adjustment of the conversion price to $9.57 per share from September 19, 2024 to November 29, 2024. Following that date, the conversion price would have reverted back to $10.98 per share and the exchange rate would have reverted back to 91.0972 shares of the Company’s Class A Common Stock per $1,000 principal amount of Notes. A notice was sent to all holders of Exchangeable Notes on October 9, 2024 providing details of these choices. All Exchangeable Notes were exchanged prior to November 29, 2024. An aggregate of $130,000 of the Notes were surrendered and exchanged for an aggregate of 13,587,565 newly-issued shares of Class A Common Stock.

The Company assessed all terms and features of the Exchangeable Notes in order to identify any potential embedded features that would require bifurcation. As part of this analysis, the Company assessed the economic characteristics and risks of the Exchangeable Notes, including the conversion, put and call features. In consideration of these provisions, the Company determined that the optional redemption with a make-whole provision feature required bifurcation as a derivative liability. The fair value of the optional redemption with a make-whole provision feature was determined based on the difference between the fair value of the notes with the redemption with a make-whole provision feature and the fair value of the notes without the redemption with a make-whole provision feature. The Company employed a Lattice model to determine the fair value of the derivative liability upon issuance of the Exchangeable Notes and at the end of each reporting period when the derivative liability was remeasured to its fair value. The Company recorded a favorable (unfavorable) change in fair value of $425, $(139) and $266 for the years ended December 31, 2024, 2023 and 2022. The derivative liability was written off when the Exchangeable Notes were surrendered and exchanged in 2024.

During the years ended December 31, 2024, 2023 and 2022 the Company recognized $4,568, $9,585 and $9,536, respectively, of interest expense related to the Exchangeable Notes at the effective interest rate of 7.4%.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Credit Facility

On July 26, 2016, the Company, through its subsidiary, Holdings, entered into a $120,000 credit facility (the “2016 Credit Facility”) with J.P. Morgan Chase (“JPMC”) as the lending agent that provided the Company with a revolving credit facility with a maximum borrowing capacity of $40,000 (the “2016 Revolver”) and a term loan of $80,000 (the “2016 Term Loan”) that was scheduled to mature in July 2021. The 2016 Credit Facility was subsequently amended in July 2019, November 2020 and December 2021 (the “2021 Credit Facility”) to increase the borrowing capacity of the 2016 Revolver and the 2016 Term Loan and to extend the maturity date of the 2016 Credit Facility. The 2021 Credit Facility increased the overall borrowing capacity of the credit facility to $310,000 comprised of a revolving credit facility with a maximum borrowing capacity of $60,000 (the “2021 Revolver”) and a term loan of $250,000 (the “2021 Term Loan”). The 2021 Credit Facility was set to mature on December 16, 2025. The 2021 Credit Facility was also amended in February 2023, May 2023 and March 2024 to (i) transition the 2021 Credit Facility from bearing interest based on LIBOR to Secured Overnight Financing Rate Data ("SOFR"), (ii) to remove certain lenders who no longer wanted to participate in the 2021 Credit Facility, and (iii) to allow the Company to repurchase outstanding shares of common stock, common stock warrants and Exchangeable Notes in an aggregate amount not to exceed $40,000. The 2021 Credit Facility was accounted for as a modification and approximately $1,800 of additional costs incurred in connection with the modification were capitalized as debt issuance costs.

On August 7, 2024, the Company entered into a Fourth Amended and Restated Credit Agreement with JPMC (the “2024 Credit Facility” and collectively with the 2021 Credit Facility, the “Credit Facilities”) and the lenders party thereto to refinance the 2021 Credit Facility. The 2024 Credit Facility amended and restated the 2021 Credit Facility in its entirety. In conjunction with the 2024 Credit Facility, the maximum borrowing capacity of the overall credit facility was increased to $330,000 comprised of a term loan of $200,000 (the “2024 Term Loan”) and a revolving credit facility of $130,000 (the “2024 Revolver”). Two lenders who participated in the 2021 Credit Facility did not participate in the 2024 Credit Facility and transferred their debt to other lenders. The 2024 Credit Facility is set to mature on August 7, 2029. The 2024 Credit Facility was accounted for as an extinguishment for thetwo lenders who transferred their debt and as a modification for all other remaining lenders. As a result, the Company wrote-off approximately $148 in unamortized debt issuance costs related to the lenders who did not participate in the 2024 Credit Facility which is included in Loss on Extinguishment of Debt in Other Expense in the accompanying consolidated statements of operations.

In conjunction with the 2024 Credit Facility, the Company incurred approximately $686 in lender fees and $147 in other third-party fees related to the 2024 Revolver and approximately $1,056 in lender fees and $225 in other third-party fees related to the 2024 Term Loan. The $1,056 of lender fees related to the 2024 Term Loan have been capitalized and these fees, along with $832 of unamortized debt issuance costs related to the 2021 Credit Facility, will be amortized into interest expense through the maturity date of the 2024 Term Loan using the effective interest method. Similarly, $686 of lender fees and $147 of other third-party fees related to the 2024 Revolver have been capitalized as an other long-term asset and will be amortized into interest expense through the maturity date of the 2024 Revolver using the straight-line method. The $225 other third-party fees related to the 2024 Term Loan were expensed as incurred.

On December 30, 2024, the Company executed Amendment No. 1 to the 2024 Credit Facility (the "December 2024 Amendment") to allow the Company to facilitate a spin-off of a newly formed entity, Resolute Holdings Management, Inc. See Note 18 for additional discussion of the spin-off. There were no changes to the lenders as a result of the December 2024 Amendment and the December 2024 Amendment was accounted for as a debt modification. In connection with the December 2024 Amendment, the Company incurred $215 in lenders fees which were capitalized and will be amortized to interest expense through the maturity of the 2024 Credit Facility.

The Company’s Credit Facility, requires the Company to make quarterly principal payments until maturity, at which point a balloon principal payment is due for the outstanding principal. The Credit Facilities also require the Company to make monthly interest payments as well as pay a quarterly unused commitment fee of 0.35% for any unused portion of the revolving credit facilities. Both the 2021 Credit Facility and the 2024 Credit Facility provide for the Company to prepay the term loans without penalty or premium. The Credit Facilities are secured by substantially all of the assets of the Company.

Interest on the revolving credit facility and the term loan are based on outstanding principal amount during the interest period multiplied by the quoted SOFR rate plus the applicable margin of 1.75% to 2.75% based on the Company's leverage ratio. At December 31, 2024 and 2023, the effective interest rate on the Revolver and Term Loan was 6.81% and 7.80% per year, respectively.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The Company recognized $16,510, $19,513 and $14,188 of interest expense related to the revolving credit facility and term loan for the years ended December 31, 2024, 2023 and 2022, respectively.

The Credit Facilities contain certain financial covenants including a minimum interest coverage ratio, a maximum total debt to EBITDA ratio and a minimum fixed charge coverage ratio. As of December 31, 2024 and 2023, the Company was in compliance with all financial covenants. The fair value of the Company's Credit Facilities approximate the carrying value for all periods presented.

As of December 31, 2024 and 2023, there wereno balances outstanding on the Revolver. As of December 31, 2024, there was $130,000 of availability for borrowing under the Revolver.

December 31,2024 · December 31,2023
Term Loan · Exchangeable Notes · Total debt · Term Loan · Exchangeable Notes · Total debt
Loan Balance$197,500$—$197,500$210,313$130,000$340,313
Less: current portion of term loan (scheduled payments)(11,250)—(11,250)(10,313)—(10,313)
Less: net deferred financing and discount costs(1,861)—(1,861)(1,669)(2,168)(3,837)
Total long-term debt$184,389$—$184,389$198,331$127,832$326,163
Derivative liability - redemption with make-whole provision$—$425

The maturity of the all the borrowing facilities is as follows:

Years ending December 31,
2025$11,250
202615,000
202716,250
202820,000
2029135,000
Total debt$197,500

In order to hedge the Company’s exposure to variable interest rate fluctuations related to the $310,000 of borrowings under its 2021 Credit Facility, the Company entered intotwo interest rate swap agreements with Bank of America on January 11, 2022, the first of which had an effective date of January 5, 2022 (the “January 2022 Swap”), and the second of which had an effective date of December 5, 2023 (the “December 2023 Swap” and, collectively with the January 2022 Swap, the “Interest Rate Swap Agreements”). The January 2022 Swap expired on December 5, 2023 while the December 2023 Swap is set to expire on December 2025. Both the January 2022 Swap and the December 2023 Swap are settled at the end of the month between the parties. The December 2023 Swap has a notional amount of $125,000 and was designated as a cash flow hedge for accounting purposes.

The Company determined the fair value of the Interest Rate Swap Agreements to bezero at the inception of the agreements and $2,749 and $5,258 at December 31, 2024 and 2023 respectively. The Company reflects the realized gains and losses of the actual monthly settlement activity of the Interest Rate Swap Agreements through interest income or expense in its consolidated statements of operations. The Company reflects the unrealized changes in fair value of the Interest Rate Swap Agreements at each reporting period in other comprehensive income. A derivative asset or liability is recognized at each reporting period in the Company’s consolidated balance sheets for the Interest Rate Swap Agreements. Interest related to the Interest Rate Swap Agreements converted from LIBOR to SOFR at the same time as the amendment of 2021 Credit Facility in February 2023.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

  1. Leases

The Company leases certain office space and manufacturing space under arrangements currently classified as leases under ASC 842 -Leases. The Company recognizes lease expense for these leases on a straight-line basis over the lease term. Most leases include one or more options to renew, with renewal options ranging fromone tofive years. The exercise of lease renewal options is at the Company’s sole discretion.

The Company’s leases have remaining lease terms ofone tofive years. The Company does not include any renewal options in lease terms when calculating lease liabilities as the Company is not reasonably certain that it will exercise these options. Two of the Company's leases provide an early termination option, however, the option was not included in the lease terms when calculating the lease liability since the Company determined that it is reasonably certain the Company will not terminate the leases prior to the termination date.

The weighted-average remaining lease term for the Company's leases is 3.2 years as of December 31, 2024. The weighted-average discount rate used in the measurement of the lease liabilities was 2.97% as of December 31, 2024.

The Company has lease agreements that contain both lease and non-lease components. The Company accounts for lease components together with non-lease components (e.g., common-area maintenance). Variable lease costs are based on day to day common-area maintenance costs related to the lease agreements and are recognized as incurred.

The components of lease costs were as follows:

Year Ended December 31,
202420232022
Short -term lease costs$1,216$1,197$1,086
Operating lease costs1,1271,0371,062
Variable lease costs$505$492$359
Total lease cost$2,848$2,726$2,507

Future minimum commitments under all non-cancelable operating leases are as follows:

Year Ended December 31,
2025$2,502
20262,240
2027912
2028846
2029359
Total lease payments6,859
Less: Imputed interest(858)
Present value of lease liabilities$6,001

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Supplemental cash flow information and non-cash activity related to our operating leases are as follows:

Year Ended December 31,
202420232022
Operating cash flow information:
Cash paid for amounts included in the measurement of lease liabilities$2,446$2,303$1,700
Non-cash activity:
Right-of-use assets obtained in exchange for lease obligations$—$491$5,104
  1. EQUITY STRUCTURE

Shares Authorized

As of December 31, 2024, the Company had authorized a total of 250,000,000 shares for issuance designated as Class A Common Stock,75,000,000 designated as Class B Common Stock and 10,000,000 shares designated as preferred stock. As of December 31, 2024, there were 100,462,844 shares of Class A Common Stock issued and outstanding, no shares of Class B Common Stock issued and outstanding andno shares of Preferred Stock issued and outstanding.

Issuance of Common Stock

During the year ended December 31, 2024, the Company issued 3,865,582 new shares of Class A Common Stock pursuant primarily to the vesting of certain restricted stock units ("RSUs"), performance stock units ("PSUs") and exercises of stock options, as well as employee stock purchase plan ("ESPP") transactions. The Class A Common Stock issued pursuant to the vesting of RSUs were issued net of shares withheld for applicable taxes.

On December 13, 2024, a stock price threshold associated with an Earnout was achieved. As a result of the achievement 3,635,924 shares of Class A Common Stock were issued, which is net of 114,076 shares that were withheld to pay taxes. See Note 11 for additional discussion of the Earnout.

Through December 31, 2024, all $130,000 of the Exchangeable Notes had been surrendered and exchanged for an aggregate of 13,587,565 newly-issued shares of Class A Common Stock, and none were outstanding at December 31, 2024 (see Note 6).

During May 2024, certain holders of the shares of Class B Common Stock exchanged an aggregate of 8,050,000 Class B units in Holdings (together with the corresponding number of shares of the Company's Class B Common Stock) in exchange for 8,050,000 shares of Class A Common Stock (the "Exchange"). Upon the Exchange, the exchanged shares of Class B Common Stock and the corresponding number of shares of Class B units were canceled. Immediately following the Exchange, pursuant to an Underwriting Agreement, dated as of May 8, 2024, (the “Underwriting Agreement”), by and among the Company, Holdings, the Representatives, the Underwriters and the Selling Stockholders named therein, the Selling Stockholders sold 8,050,000 shares of the Company’s Class A Common Stock to the Underwriters (the "Secondary Offering"). The Company did not receive any proceeds from the sale of the shares of Class A Common Stock by the selling stockholders. As a result of these transactions, the number of outstanding shares of the Company’s Class B Common Stock decreased by 8,050,000 and the number of outstanding shares of the Company’s Class A Common Stock increased by 8,050,000. Transaction costs of $586 were incurred and expensed related to this transaction.

On August 9, 2024, all of the Class B stockholders of the Company and Resolute entered into the Resolute Transaction which was completed on September 17, 2024, eliminating the Company's existing dual-share class structure. At the closing, the selling stockholders exchanged their 51,908,422 Class B units (and corresponding Class B shares) for Class A shares and Resolute became the majority owner of the Company by acquiring 49,290,409 of such Class A shares. Prior to the Resolute Transaction, Class B holders held units in Holdings. Subsequent to the Resolute Transaction, CompoSecure owned

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

100% of Holdings. The Company did not receive any proceeds from the sale of the shares of Class A company stock by the selling shareholders. Transaction costs of $2,726 were incurred and expensed related to this transaction.

Warrants

As of December 31, 2024 and 2023, the Company had 22,415,179 and 22,415,389 warrants outstanding. Until the expiration date of December 27, 2026, each warrant entitles the registered holder to purchaseone share of the Company’s Class A Common Stock at a price of $11.50 per share, subject to adjustment. The exercise price of the warrants was adjusted to $7.97 as the result of the spin-off of Resolute Holdings Management, Inc. See Note 18 for additional discussion of the spin-off. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares.

Special Dividend and Distribution

On May 6, 2024, the Company announced a special cash dividend of $0.30 per share to Class A stockholders. A corresponding distribution of $0.30 per share was also announced for Class B unitholders of Holdings. Both the dividend and the distribution were paid on June 11, 2024. Dividends of $8,922 were disbursed to Class A stockholders and distributions of $15,573 were disbursed to Class B unitholders.

Non-Controlling Interest

Non-controlling interests represent direct interests held in Holdings other than by the Company after the Business Combination. The non-controlling interests in the Company are represented by Class B Units, or such other equity securities in the Holdings as the Board may establish in accordance with the terms hereof. Since the potential cash redemptions of the non-controlling interests are outside the control of the Company, such non-controlling interests are classified as temporary equity on the consolidated balance sheet in accordance with ASC 480, Distinguishing liabilities from equity("ASC 480"). Income tax benefit or provision is applied to the income attributable to the controlling interest as the income attributable to the non-controlling interest is pass-through income.

As of December 31, 2024, the Company did not have any non-controlling interest as a result of the exchange of

all Class B shares for Class A shares, in connection with the acquisition of a majority interest in the Company by Resolute. The non-controlling interest was adjusted to redemption value as of December 31, 2023 in accordance with ASC 480-10. This measurement adjustment results in a corresponding adjustment to shareholders’ deficit through adjustments to additional paid-in capital and retained earnings. The redemption value of the Class B Units was $596,587 as of December 31, 2023. The redemption value is calculated by multiplying the 59,958,422 Class B Units by the $9.95 trading price of the Company's Class A Common Stock on December 27, 2021.

  1. EQUITY COMPENSATION

The following table summarizes share-based compensation expense included in selling, general and administrative expenses within the consolidated statements of operations:

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Year Ended December 31,
202420232022
Restricted stock unit expense$17,652$14,753$10,173
Performance stock unit expense2,5882,369—
Stock option expense856$3051,228
Employee stock purchase plan13913525
Incentive units——39
Total stock-based compensation expense$21,235$17,562$11,465

Equity Incentive Plan

In connection with the business combination consummated on December 27, 2021, the Company established the CompoSecure, Inc. 2021 Incentive Equity Plan (the “2021 Plan”) effective as of December 27, 2021. The purpose of the 2021 Plan is to provide eligible employees of the Company and its subsidiaries, certain consultants and advisors who perform services for the Company or its subsidiaries, and non-employee members of the Board of Directors of the Company, with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units, and other stock-based awards. The aggregate authorized number of shares of Class A Common Stock that may be issued or transferred as of December 31, 2024 under the 2021 Plan was 7,326,820 shares of Class A Common Stock plus the number of shares of Class A Common Stock underlying grants issued under the Company’s existing amended and restated equity compensation plan that expire, terminate or are otherwise forfeited without being exercised. Pursuant to this provision, effective January 1, 2025, the shares of Class A Common Stock authorized under the 2021 Plan were increased by 4,018,514 shares, for a new aggregate authorized number of shares of 11,345,334.

The aggregate authorized number of shares of Class A Common Stock that may be issued or transferred as of December 31, 2023 under the 2021 Plan was 6,680,253 shares of Class A Common Stock plus the number of shares of Class A Common Stock underlying grants issued under the Company’s existing amended and restated equity compensation plan that expire, terminate or are otherwise forfeited without being exercised. Pursuant to this provision, effective January 1, 2024, the shares of Class A Common Stock authorized under the 2021 Plan were increased by 3,321,334 shares, for a new aggregate authorized number of shares of 10,033,262. Commencing with the first business day of each calendar year beginning in 2022, the aggregate number of shares of Class A Common Stock that may be issued or transferred under the Plan shall be increased by an amount of shares of Class A Common Stock equal to 4% of the aggregate number of shares of Class A Common Stock and Class B Common Stock outstanding as of the last day of the immediately preceding calendar year, or such lesser number of shares of Class A Common Stock as may be determined by the Board.

During the years ended December 31, 2024 and 2023 the Company granted Restricted stock units (“RSU”) to employees that generally vests over a period oftwo years orfour years of continuous service. Certain grants made in 2024 vest inthree tranches at the third, fifth and seventh anniversary of the grant. RSUs granted to the Board of Directors generally vest over a period ofone year. The restricted stock will generally be forfeited upon termination of an employee prior to vesting. The fair value of each RSU is based on the market value of the Company's stock on the date of grant. During the years ended December 31, 2024 and 2023, the Company awarded officers with 872,685 and 658,156 PSUs, respectively, which vest upon three years of continuous employment and the achievement of certain performance targets. PSUs with performance conditions are valued based on the market value of the Company's stock on the date of grant and expensed based on the probability of achieving performance targets. PSUs with market conditions are valued using a Monte Carlo simulation model that utilizes significant assumptions, including volatility and the probability of satisfying the market condition and are expensed ratably over the service period.

During the year ended December 31, 2024, the Company granted options which vest over four years. No options were granted during 2023 or 2022. The fair value of each option award was estimated at the date of grant using the Black-Scholes option valuation model. The expected term assumption reflected the period for which the Company believed the option will remain outstanding. This assumption was based upon the historical and expected behavior of the Company employees. To determine volatility, the Company had used the historical closing values of comparable publicly held entities.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The risk-free rate reflected the U.S. Treasury yield curve for a similar expected life instrument in effect at the time of the grant.

A summary of RSU, PSU and stock option activity under the Plan during the year ended December 31, 2024 is presented below:

Restricted Stock Unit Activity

Number of SharesWeighted Average Grant Date Fair Value Per Share
Nonvested at January 1, 20245,651,895$6.93
Granted2,831,9007.85
Vested(2,215,284)6.24
Forfeited(51,850)5.48
Nonvested at December 31, 20246,216,6617.67

Unrecognized compensation expense for RSUs was $31,130 as of December 31, 2024 and is expected to berecognized over a remaining term of 2.1 years.

Performance and Market based Stock Units Activity

Number of SharesWeighted Average Grant Date Fair Value Per Share
Nonvested at January 1, 20241,107,536$7.14
Granted872,6855.72
Vested(224,690)7.89
Forfeited——
Nonvested at December 31, 20241,755,5316.48

Unrecognized compensation expense for PSUs was $4,743 as of December 31, 2024 and is expected to berecognized during the next 1.6 years

Stock Options

The assumptions utilized to calculate the value of the options granted for the year ended December 31, 2024 were as below:

December 31, 2024
Expected term6.25 years
Volatility47.81%
Risk-free rate3.54%
Expected dividends0%
Expected forfeiture rate0%

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The following table sets forth the options activity under the Company equity plan for the year ended December 31, 2024:

Number of SharesWeighted Average Exercise Price Per SharesWeighted Average Remaining Contractual Term (years)Aggregate Intrinsic Value(in thousands)
Outstanding at January 1, 20243,278,463$1.882.9$11,780
Granted1,915,53213.859.82,840
Exercised(2,918,324)$1.552.0$24,669
Outstanding at December 31, 20242,275,671$12.398.9$6,698
Vested and expected to vest at December 31, 20242,275,671$12.398.9$6,698
Exercisable at December 31, 2024360,133$4.624.4$3,858

The weighted average grant date fair value of options granted during the year ended December 31, 2024 was $13.85. The Company recognized approximately $856, $305, and $1,228 of compensation expense for the options in selling, general and administrative expenses in the accompanying consolidated statements of operations for the years ended December 31, 2024, 2023, and 2022, respectively.

The number of options that have vested and are exercisable as of December 31, 2024, 2023, and 2022 were 360,133,3,274,954 and 4,616,197 respectively. The weighted average exercise price of options exercisable and vested is $4.62, $1.88, and $1.29 for years ended December 31, 2024, 2023, and 2022, respectively. The weighted average remaining contractual term (years) of options exercisable as of December 31, 2024, 2023, and 2022 is 4.4,2.9, and 3.1, respectively. Total intrinsic value of options exercised is $24,669, $9,465 and $3,180 for the years ended December 31, 2024, 2023, and 2022, respectively. The weighted-average fair value of options that exercised were $1.55, $0.41 and $0.01 during the years ended December 31, 2024, 2023, and 2022, respectively. Unrecognized compensation expense for the options of approximately$12,906 is expected to berecognized during the next 3.9 years.

Employee Stock Purchase Plan

Effective December 27, 2021, the Board of Directors approved the Employee Stock Purchase Plan (the “ESPP”). The Company had authorized 2,411,452 aggregate number of shares of Class A Common Stock reserved for sale pursuant to the ESPP Plan. The ESPP permitted participating eligible employees to purchase shares of Class A Common Stock, with after-tax payroll deductions, on a quarterly basis at a 15% discount at the lower of the closing price of the Common Stock on the Nasdaq Global Market on the first day of the offering period or the last trading day of each purchase period. As of December 31, 2024 and 2023, there were 2,245,224 and 2,312,747 shares of Class A Common Stock remaining authorized for issuance under the ESPP, respectively. The Company recognized the discount on the Common Stock issued under the ESPP as stock-based compensation expense in the period in which the employees began participating in the ESPP. For the years ended December 31, 2024, 2023 and 2022 the Company issued 91,012 ,80,446 and 18,259 shares and recognized compensation expense of $139, $135 and $25 respectively. The Company terminated the ESPP effective December 31, 2024.

As a result of the Business Combination, certain of Holdings' equity holders have the right to receive an aggregate of up to 7,500,000 additional shares of the Company's Class A Common Stock in earnout consideration based on the achievement of certain stock price thresholds (See Note 18 in Notes to Consolidated Financial Statements in this Form 10-K for further discussion) (collectively, the “Earnouts”). The Earnouts were subject to two price thresholds, with half to be awarded upon the achievement of each threshold. The Earnouts expire in two phases if the achievement thresholds are not met. The first phase was to expire upon thethree-year anniversary of the Closing Date of the Business Combination, and the second phase is set to expire upon thefour year anniversary of the Closing Date. The earnouts under the first phase were

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

achieved on December 13, 2024. The second phase has not yet been achieved. A total of 657,160 shares or 328,580 shares for each phase were issued to employees and were accounted for in accordance with ASC 718 as they were considered to be compensation. The following is a summary of the earnout activity for the year ended December 31, 2024:

Number of Shares
Outstanding at January 1, 2024657,160
Granted—
Vested(328,580)
Nonvested at December 31, 2024328,580

Upon the Business Combination, a valuation was performed which took into consideration all the key terms and conditions of the award, including the fact that, under Topic 718, there is no requisite service period due to the fact that there is no service condition prospectively, and as of the grant date there is no service inception date preceding the grant date on which to base historical valuation or expense amortization. As such, the award is considered to be immediately vested from a service perspective and is solely contingent on meeting the hurdles required for the award to be settled. Since there is no future substantive risk of forfeiture, all expenses associated with the awards were accelerated and recognized on December 27, 2021.

  1. RETIREMENT PLAN

Defined Contribution Plan

The Company has a 401(k) profit sharing plan for all full-time employees who have attained the age of 21 and have completed 90 days of service. Through December 31, 2024, the Company matched 100% of the first 1% and then 50% of the next 5% of employee contributions. Retirement plan expense for the years ended December 31, 2024, 2023, and 2022 was $1,962, $1,813, and $1,614, respectively. Beginning January 1, 2025, the Company will match 100% of the first 3% and then 50% of the next 2% of employee contributions.

  1. FAIR VALUE MEASUREMENTS

In accordance with ASC 820-10, the Company evaluates assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level at which to classify them for each reporting period. This determination requires significant judgments to be made by the Company.

The Company’s financial assets and liabilities measured at fair value on a recurring basis, consisted of the following types of instruments as of the following dates:

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Level 1Level 2Level 3Total
Assets Carried at Fair Value:
Derivative asset - interest rate swap$—$2,749$—$2,749
Liabilities Carried at Fair Value:
Warrants$104,231$—$—$104,231
Earnout consideration——20,53320,533
Derivative liability - redemption with make-whole provision————
Assets Carried at Fair Value:
Derivative asset - interest rate swap$—$5,258$—$5,258
Liabilities Carried at Fair Value:
Warrants$8,294$—$—$8,294
Earnout consideration——853853
Derivative liability - redemption with make-whole provision——425425

Derivative asset - interest rate swap

The Company is exposed to interest rate risk on variable interest rate debt obligations. To manage interest rate risk, the Company entered into an interest rate swap agreement on January 5, 2022. See Note 6.

Warrant Liability

As a result of the Business Combination, the Company had assumed a warrant liability related to previously issued warrants in connection with Roman DBDR's initial public offering. The warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the consolidated balance sheets. The warrant liabilities were remeasured at December 31, 2024 and 2023 with changes in fair value presented within revaluation of warrant liabilities in the consolidated statement of operations.

The following table provides a reconciliation of the ending balances for the warrant liabilities remeasured at fair value:

Warrant Liabilities
Estimated fair value at December 31, 2022$16,341
Change in estimated fair value(8,047)
Estimated fair value at December 31, 2023$8,294
Change in estimated fair value95,937
Estimated fair value at December 31, 2024$104,231

The Warrants were valued using the quoted market price as the fair value at the end of each balance sheet date.

Holdings' equity holders have the right to receive an aggregate of up to 7,500,000 additional shares of the Company's Class A Common Stock, in Earnout consideration based on the achievement of certain stock price thresholds (See Note 18 in Notes to Consolidated Financial Statements in this Form 10-K for further discussion). See also Note 9. Earnout consideration liabilities held by Holdings' holders (not including the holders under ASC 718) were determined to be derivative instruments in accordance with ASC 815 and were accounted as derivative liabilities, initially valued at fair value

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

in accordance with ASC 815-40-30-1. Subsequently, the liability for Earnouts will be remeasured at each reporting period at fair value, with changes in fair value recorded in earnings in accordance with ASC 815-40-35-4. The Company established the initial fair value for the earnouts at the closing date on December 27, 2021 using a Monte Carlo simulation model.

The earnouts achievement were subject to two price thresholds with half of the shares to be issued upon the achievement of each threshold. The earnouts expire intwo phases if the achievement thresholds are not met. The first phase was to expire December 27, 2024 and the second phase is set to expire on December 27, 2025. The earnouts under the first phase were achieved on December 13, 2024. The Company remeasured the fair value of the earnouts outstanding at each reporting period. As the first phase of the earnout was achieved on December 13, 2024, the related earnout was remeasured to its fair value at that time and the related liability was relieved to equity. The following table provides a reconciliation of the ending balances for the earnout consideration liabilities remeasured at fair value:

Earnout Consideration Liability
Estimated fair value at December 31, 2022$15,090
Change in estimated fair value(14,237)
Estimated fair value at December 31, 2023$853
Change in fair value of Phase 1 on achievement date56,564
Settlement of Phase 1 on December 13, 2024(56,625)
Change in estimated fair value of Phase 219,741
Estimated fair value at December 31, 2024$20,533

The following assumptions were used to determine the fair value of the Earnout consideration for the periods indicated below:

December 31,
20242023
Valuation date share price$15.33$5.40
Risk-free interest rate4.16%4.23% - 4.79%
Expected volatility35.0%35% - 42.5%
Expected dividends0%0%
Expected term (years)1 years1 - 2 years

The fair value of Earnout consideration liabilities have been classified as a Level 3 liability as its valuation requires substantial judgment and estimation of factors that are not currently readily observable in the market. The expected term assumption reflected the period for which the instrument will remain outstanding. To determine volatility, the Company had used the historical closing values of comparable publicly held entities to estimate volatility. The risk-free rate reflected the U.S. Treasury yield curve for a similar expected life instrument in effect at the reporting date. If different assumptions were used for the various inputs to the valuation approach, the estimated fair value could be significantly higher or lower than the fair value determined.

  1. GEOGRAPHIC INFORMATION AND CONCENTRATIONS

The Company headquarters and substantially all of its operations, including its long-lived assets, are located in the United States. Geographical revenue information based on the location of the customer follows:

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Year Ended December 31,
202420232022
Net sales by country
Domestic$343,465$321,470$295,423
International77,10669,15983,053
Total$420,571$390,629$378,476

The Company’s principal direct customers as of December 31, 2024 consist primarily of leading international and domestic banks and other credit card issuers primarily within the U.S., Europe, Asia, Latin America, Canada, and the Middle East. The Company periodically assesses the financial strength of these customers and establishes allowances for anticipated losses, if necessary.

Two customers individually accounted for more than 10% of the Company’s revenue or 63.2% of total revenue for the year ended December 31, 2024. Two customers individually accounted for more than 10% of the Company’s revenue or 70.5% of total revenue for the year ended December 31, 2023. Two customers individually accounted for more than 10% of the Company’s revenue or 67.3% of total revenue for the year ended December 31, 2022. Four customers individually accounted for more than 10% of the Company’s accounts receivable or 70% as of December 31, 2024 and two customers individually accounted for 10% of total accounts receivable or 73% as of December 31, 2023.

The Company primarily relied on one vendor that individually accounted for more than 10% of purchases of supplies for the year ended December 31, 2024. The Company primarily relied on three vendors that individually accounted for more than 10% of purchases of supplies for the year ended December 31, 2023.

  1. INCOME TAXES

The Company recorded income tax provision of $2,187, $4,556 and $4,360 for the year ended December 31, 2024, 2023 and 2022. Federal, state and local income tax returns for years prior to 2019 are no longer subject to examination by tax authorities. During the year ended December 31, 2024, federal tax authorities completed their audit of fiscal 2020. There were no proposed adjustments resulting from the examination.

Income before the provision and benefit for income taxes as shown in the accompanying consolidated statements of operations is as follows:

Year Ended December 31,
202420232022
Income (loss) before income taxes$(80,975)$117,076$136,175

The components of the provision for income taxes for the year ended December 31, 2024, 2023 and 2022 consisted of the following:

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

Year Ended December 31,
202420232022
Current:
Federal$4,454$1,810$1,140
State2027927
4,6561,8891,167
Deferred:
Federal(2,387)3,0913,477
State(82)(424)(284)
(2,469)2,6673,193
Total provision for income taxes$2,187$4,5564,360

The reconciliation of income taxes at the federal statutory rate to provision for income taxes for the years ended December 31, 2024, 2023 and 2022 were as follows:

Year Ended December 31,
202420232022
U.S. federal statutory tax rate21.00%21.00%21.00%
State taxes0.72%0.72%0.28%
Valuation allowances13.82%3.26%1.11%
NCI adjustment(15.29)%(17.37)%(17.52)%
Permanent differences3.80%(3.82)%(0.64)%
Fair Value Adjustments: Warrants & Liabilities(26.84)%—%—%
OCI Adjustment(0.08)%0.09%(0.27)%
Other temporary differences0.17%0.01%(0.76)%
Effective income tax rate(2.70)%3.89%3.20%

The Company’s overall effective tax rate is affected by the Resolute Transaction. As a result of the Resolute Transaction, Holdings became 100 percent owned by the Company, thereby eliminating the Up-C structure. This resulted in the release of certain valuation allowances and changes in tax benefit allocations.

Provisions have been made for deferred taxes based on the differences between the basis of the assets and liabilities for financial statement purposes and the basis of the assets and liabilities for tax purposes using currently enacted tax rates and regulations that will be in effect when the differences are expected to be recovered or settled.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The components of the deferred tax assets were as follows:

December 31,
20242023
Deferred Tax Assets:
Investment in Holdings$—$34,162
Imputed Interest—727
IRC 755 - Fixed Assets838—
IRC 755 -Intangible Assets257,867—
Inventory - 263A74—
Inventory Reserve609—
R&D Capitalized Costs5,328—
Accrued Expenses2,453—
Equity Compensation1,962—
Stock Options/ RSU's—1
Total deferred tax assets$269,131$34,890
Valuation Allowance—(11,193)
Prepaid Insurance(564)—
Fixed Assets(3,607)—
Right of Use Assets, net of lease liability(145)—
Total deferred tax assets, net of valuation allowance and deferred liability$264,815$23,697

Deferred taxes primarily result from the Business Combination where the Company recorded a carryover basis on all assets for financial accounting purposes and a fair value step-up on a portion of the assets for income tax purposes. As a result of the Resolute Transaction, the Company owned 100 percent of Holdings, which triggered the conversion from Investment in Holdings in deferred tax assets into specific deferred tax items, most notably the increase in IRC 755 - Intangible Assets. The Company’s deferred tax asset was reviewed for expected utilization using a “more likely than not” approach by assessing the available positive and negative evidence surrounding its recoverability. As of December 31, 2024, the Company determined that considering all of these factors, a $0 valuation allowance would be established, a decrease in valuation allowance of $11,193 compared to the year ended December 31, 2023. The Company will continue to assess and evaluate strategies that will enable the deferred tax asset, or portion thereof, to be utilized, and will reduce the valuation allowance appropriately at such time when it is determined that the “more likely than not” criteria is satisfied.

There wereno significant uncertain tax positions taken, or expected to be taken, in a tax return that would be determined to be an unrecognized tax benefit taken or expected to be taken in a tax return that should have been recorded on the Company’s financial statements for the years ended December 31, 2024, 2023 and 2022. Additionally, there wereno interest or penalties outstanding as of the fiscal year ended December 31, 2024, 2023 and 2022.

On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”). Under the provisions of the CARES Act, the Company is eligible for a refundable employee retention credit subject to certain criteria. In connection with the CARES Act, the Company adopted a policy to recognize the employee retention credit when realized under ASC 450-30. Accordingly, the Company recorded a $1,291 employee retention credit during the year ended December 31, 2022, which is reported as other income in the consolidated statements of operations.

  1. EARNINGS PER SHARE

Basic net (loss) per share has been computed by dividing net (loss) attributable to Class A common shareholders for the periods subsequent to the Business Combination by the weighted average number of shares of common stock outstanding for the same period. Diluted earnings per share of Class A Common Stock was computed by dividing net (loss) available to CompoSecure, Inc. by the weighted-average number of shares of Class A Common Stock outstanding adjusted to give effect to potentially dilutive securities.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The following table sets forth the computation of net income used to compute basic net income per share of Class A Common Stock for the years ended December 31, 2024, 2023 and 2022 respectively.

Year Ended December 31,
202420232022
Basic and diluted:
Net (loss) income$(83,162)$112,520$131,815
Less: Net (loss) income attributable to non-controlling interest(29,443)93,281113,158
Net (loss) income attributable to Class A Common shareholders$(53,719)$19,239$18,657
Plus: adjustment due to net effect of equity awards, Exchangeable Notes and class B units to net income—14,82518,017
Net (loss) income attributable to Class A Common shareholders after adjustment$(53,719)$34,064$36,674
Weighted average common shares outstanding used in computing net (loss) income per share - basic44,011,52718,660,87215,372,422
Plus: net effect of dilutive equity awards, Exchangeable Notes and Class B units—16,651,23917,182,895
Weighted average common shares outstanding used in computing net (loss) income per share - diluted44,011,52735,312,11132,555,317
Net (loss) income per share—basic$(1.22)$1.03$1.21
Net (loss) income per share—diluted$(1.22)$0.96$1.13

Securities that could potentially be dilutive are excluded from the computation of diluted earnings per share when the exercise price exceeds the average closing price of the Company’s common stock during the period, because their inclusion would result in an antidilutive effect on per share amounts. The Company applied the if-converted method for the Exchangeable Notes to calculate diluted earnings per share in accordance with ASU 2020-06.

The following amounts were not included in the calculation of net earnings (loss) per diluted share because their effects were anti-dilutive:

December 31,
202420232022
Potentially dilutive securities:
Warrants22,415,17922,415,40022,415,400
Class B common shares—59,958,42260,325,057
Earnout consideration shares3,500,0007,500,0007,500,000
Equity awards2,523,6392,679,8333,461,502
  1. COMMITMENTS AND CONTINGENCIES

Operating Leases

The Company leases certain office space and manufacturing space under arrangements currently classified as leases under ASC 842. See Note 7 for future minimum commitments under all non-cancelable operating leases.

Tax Receivable Agreement

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The Company is obligated to make payments under the tax receivable agreement to the TRA Holders. See Note 2. Although the actual timing and amount of any payments that may be made under the agreement will vary, the Company expects the cash obligation required will be significant. Any payments made under the tax receivable agreement will generally reduce the amount of overall cash flows that might have otherwise been available to the Company. To the extent that the Company is unable to make payments under the tax receivable agreement for any reason, the unpaid amounts generally will be deferred and will accrue interest until paid by the Company. The tax receivable agreement liability includes amounts to be paid assuming the Company will have sufficient taxable income over the term of the tax receivable agreement to utilize the related tax benefits. In determining the estimated timing of payments, the current year’s taxable income was used to extrapolate an estimate of future taxable income.

As of December 31, 2024, the Company had the following obligations expected to be paid pursuant to the tax receivable agreement:

Year ending December 31,
2025$5,171
202614,122
202714,283
202814,516
202914,762
Later years190,851
Total Payments$253,705

In addition to the above, the Company's tax receivable agreement liability and future payments thereunder are expected to increase as we realize (or are deemed to realize) an increase in tax basis of Holdings’ assets resulting from any future purchases, redemptions or exchanges of Holdings' interests by holders. The Company currently expect to fund these future tax receivable agreement liability payments from some of the realized cash tax savings as a result of this increase in tax basis.

Litigation

The Company may be, from time to time, party to various disputes and claims arising from normal business activities. The Company accrues for amounts related to legal matters if it is probable that a liability has been incurred and the amount is reasonably estimable. while the outcome of existing disputes and claims is uncertain, the Company does not expect that the resolution of existing disputes and claims would have a material adverse effect on its consolidated financial position or liquidity or the Company’s consolidated results of operations. Litigation expenses are expensed as incurred. In February 2021, the Company had received from a third party a notice of dispute with respect to whether commissions were due and owing on product sales to certain of the Company’s customers which could have required payments ranging from $4,000 to $14,000, plus costs and expenses. In October 2022, this dispute was resolved through binding arbitration, resulting in commission payments to the third party within the anticipated range, together with additional commission payments on future sales, if any, to one customer. The Company made a payment of $10,259 related to these commission payments during the year ended December 31, 2022.

  1. Segment Reporting

The Company hastwo operating segments andtwo reportable segments: Payment Card and Arculus. Payment Card and Arculus were concluded to be two separate reportable segments. Payment Card generates its revenue through the production and sale of metal payment cards while Arculus generates its revenue through the production and sale of metal payment or nonpayment cards containing Arculus technology for authentication and/or digital asset cold storage and related services. The accounting policies of both segments are the same as those described in the summary of significant accounting principles.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The Company accounts for Arculus and Payment on a direct cost basis, no corporate costs are allocated to either. The Company includes all senior leadership team personnel costs in Payment Card.

All others, as reported below, consists of the corporate entities that were concluded to not be operating segments and include the public company parent entity, Holdings, and Resolute Holdings and fair value adjustments related to warrants liability and earnout liability.

The chief operating decision maker ("CODM") is the Chief Executive Officer of the Company. The CODM evaluates the performance of Payment Card and Arculus primarily based on net sales, gross profit and net (loss) income. The Company does not have any intra-entity sales.

Year Ended December 31,
202420232022
Net Sales
Payment card$410,061$388,903$377,081
Arculus10,5101,7261,395
All others———
$420,571$390,629$378,476
Gross profit
Payment card$210,960$208,286$219,265
Arculus8,267796379
All others———
$219,227$209,082$219,644
Net (loss) income
Payment card$120,375$126,300$133,034
Arculus(4,583)(15,374)(22,023)
All others(198,954)1,59420,804
$(83,162)$112,520$131,815
December 31,
20242023
Identifiable assets
Payment card$232,611$181,993
Arculus5,6423,475
All others272,15028,431
Eliminations(36,485)(12,858)
$473,918$201,041

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The below table presents significant segment expenses for Payment Card.

Year Ended December 31,
2024 · 2023 · 2022
Net sales$410,061$388,903$377,081
Less:
Cost of sales (1)190,879173,269150,494
Personnel costs including variable compensation37,56232,09240,021
Marketing costs1,5111,6062,020
Professional fees7,2126,1088,133
Interest expense, net (2)12,28114,61013,008
Depreciation (1)8,5507,6747,885
Stock-based compensation19,40416,63911,166
Other segment costs (3)12,28710,60511,320
Segment net income$120,375$126,300$133,034

(1)Cost of sales presented excludes depreciation of $8.6 million, $7.6 million, and $7.3 million for each of the years ended December 31, 2024, 2023 and 2022.. The portion of depreciation that was recorded in Cost of sales is included in the Depreciation line.

(2)Includes amortization of deferred finance costs for the years ended December 31, 2024, 2023 and 2022.

(3) Other segment costs include utilities, insurance, office supplies, travel and sales and use taxes.

The below table presents significant segment expenses for Arculus.

Year Ended December 31,
2024 · 2023 · 2022
Net sales$10,510$1,726$1,395
Less:
Cost of sales (1)2,019697804
Personnel costs including variable compensation5,0976,5085,647
Marketing costs3,2713,4149,788
Professional fees2,6034,2964,175
Depreciation (1)624713690
Stock-based compensation491436299
Other segment costs9881,0362,015
Segment net income$(4,583)$(15,374)$(22,023)

(1)Cost of sales presented excludes depreciation of $0.2 million for each of the years ended December 31, 2024, 2023 and 2022. The portion of depreciation that was recorded in Cost of sales is included in the Depreciation line.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

The below table presents significant segment expenses for all others.

Year Ended December 31,
2024 · 2023 · 2022
Net sales$—$—$—
Less:
Personnel costs including variable compensation1,297——
Professional fees15,1013,2601,716
Interest expense, net (1)4,4999,5469,536
Stock-based compensation1,340487—
Fair value adjustments172,242(22,284)(42,267)
Other segment costs (2)4,4757,39710,211
Segment net loss$(198,954)$1,594$20,804

(1) Includes amortization of deferred finance costs for the years ended December 31, 2024, 2023 and 2022.

(2) Other segment costs include office supplies, travel and sales and use taxes.

  1. RELATED PARTY TRANSACTIONS

As a result of the Business Combination, the Company entered into a tax receivable agreement with Holdings and unitholders of Holdings, which was amended upon the Resolute Transaction closing as of September 17, 2024. See Note 15. The Company is obligated to make certain payments under the tax receivable agreement to certain historical unitholders of Holdings. The Company made a total payment of ,$1,303 and $2,436 related to the tax receivable agreement liability in the year ended December 31, 2024 and 2023, respectively.

Pursuant to the Holdings LLC agreement, the Company makes pro rata tax distributions to the holders of Holdings' units, (i.e. non-controlling interest) in an amount sufficient to fund all or part of their tax obligations with respect to the taxable income of Holdings that is allocated to them. For the year ended December 31, 2024, Holdings distributed a total of $50,082 of tax distributions to its members, of which $15,219 was paid to CompoSecure, Inc. (the parent company), resulting in a net tax distribution to all other members of $34,863. For the year ended December 31, 2023, Holdings distributed a total of $49,955 of tax distributions to its members, of which $11,593 was paid to CompoSecure, Inc. (the parent company), resulting in a net tax distribution to all other members of $38,362.

In connection with the special distribution discussed in Note 8, $15,573 was disbursed to Class B unitholders of Holdings on June 11, 2024.

In connection with the Resolute transaction, on September 17, 2024, the Company and Resolute entered into the Governance Agreement, pursuant to which the Company and Resolute established certain governance matters, including ongoing obligations with respect to the size of the board of directors, election of specified directors (including independent directors) and other matters. The foregoing summary of the Governance Agreement is not complete and is qualified in its entirety by reference to the full text of such document, attached hereto as Exhibit 10.37, which is incorporated herein by reference.

COMPOSECURE, INC.

Notes to Consolidated Financial Statements

(amounts in thousands, except share data)

  1. SUBSEQUENT EVENT

Spin-off

On February 28, 2025, the Company completed the previously-announced spin-off (the "Spin-Off") of Resolute Holdings Management, Inc. ("Resolute Holdings"), and, in connection with the Spin-Off, CompoSecure Holdings, L.L.C. (a wholly-owned subsidiary of the Company) entered into a management agreement pursuant to which Resolute Holdings will provide management and other related services to CompoSecure Holdings, L.L.C. in exchange for payment of quarterly management fees based on 2.5% of trailing twelve-month adjusted EBITDA calculated in accordance with the management agreement. In connection with the Spin-Off, we and CompoSecure Holdings, L.L.C. entered into several other agreements with Resolute Holdings, including a separation and distribution agreement, state and local tax sharing agreement, among others. Please see the Company's Current Report on Form 8-K filed with the SEC on March 5, 2025 for additional information about such agreements, as well as copies of the agreements filed as exhibits to such Form 8-K. Resolute Holdings is an entity that the Company formed on September 27, 2024.

As a result of the Spin-Off, Resolute Holdings will consolidate the results of CompoSecure Holdings, L.L.C. Please see the Company's Current Report on Form 8-K filed with the SEC on March 5, 2025 for pro forma financial statements of the Company giving effect to the Spin-Off.

Warrant Adjustment

The Spin-Off of Resolute Holdings from the Company was achieved through the distribution of all outstanding shares of Resolute Holdings common stock, par value $$0.0001 per share (the “Resolute Holdings Common Stock”), on a pro rata basis to holders of record of the Company’s Class A Common Stock, par value $0.0001 per share (the “CompoSecure Common Stock”). Each holder of record of CompoSecure Common Stock received one share of Resolute Holdings Common Stock for every twelve shares of CompoSecure Common Stock held on February 20, 2025, the record date for the Spin-Off. In lieu of fractional shares of Resolute Holdings Common Stock, holders of CompoSecure Common Stock will receive cash.

The distribution of shares in connection with the Spin-Off constituted an Extraordinary Dividend as defined in the warrant agreement. As a result, the warrant price was decreased from $11.50 per share of CompoSecure Common Stock to $7.97 per share of CompoSecure Common Stock, and the redemption trigger price was decreased from $18.00 per share of CompoSecure Common Stock to $14.47 per share of CompoSecure Common Stock, effective as of February 28, 2025.

Earnout Adjustment

The distribution of shares in connection with the Spin-Off resulted in an adjustment to the terms of the Earnout in accordance with the Merger Agreement. The number of remaining Earnout Shares increased and the price threshold decreased, effective as of February 28, 2025.

Lease amendment

On January 22, 2025, the Company exercised a renewal option for the lease ofone of its production facilities. The lease was extended for afive-year term beginning on October 1, 2026, and ending on September 30, 2031. The aggregate anticipated base rent payments under the extension are $5.3 million.

SAFE Investment

On February 10, 2025, the Company's investment in a SAFE with Signify Holdings, Inc. (dba Rain) was converted to an equity interest under the terms of the agreement.

Other Events

Subsequent to December 31, 2024, Resolute acquired shares which resulted in Resolute owning an approximately 51% share of the Company at the time of filing of this annual report.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.